Drug and Therapy Development for Triple Negative Breast Cancer (Pravin Kendrekar)

A holistic view on TNBC that integrates the latest advances in the etiology, detection, diagnosis and treatment of this agressive cancer, laying the ground for the development of novel therapies.

Dr. Pravin Kendrekar, School of Natural Sciences, University of Central Lancashire, Preston, UK.
 
Dr. Vinayak Adimule, Angadi Institute of Technology and Management, Belagavi, India.
 
Dr. Tara Hurst, Pandemic Sciences Institute, University of Oxford, Oxford, UK.

Buch (Hardcover), Englisch, 320 Seiten